Home » CMS Pushes Back Drugmakers’ Sunshine Deadline to 2013
CMS Pushes Back Drugmakers’ Sunshine Deadline to 2013
The Centers for Medicare & Medicaid Services (CMS) is sparing drug manufacturers and group purchasing organizations (GPO) from reporting payments made to doctors and hospitals in 2012 as the agency continues to lag behind deadlines for issuing final Sunshine Act regulations. Data collection is now expected to begin in January 2013.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May